Feb 12, 2010 - Investor news: Nutri Pharma ASA has acquired 98,3% of the shares in Bionor Immuno AS. On Feb 12 the extraordinary shareholders meeting in Nutri Pharma ASA approved the aquisition of 98,3% of the shares in Bionor Immuno AS. Jan 14, 2010 - Investor news: Nutri Pharma ASA has launched a voluntary offer for Bionor Immuno AS. Voluntary offer - read more Jan 13, 2010 - Presentation: Nutri Pharma - Proposed All-share Acquisition and subsequent Offering. Presentation - read more Jan 13, 2010 - Press release: Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS Press release - read more Please contact Birger Sørensen for further information. Birger Sørensen President and CEO e-mail: bs@bionorimmuno.com phone: +47 35 90 85 02
INVESTORS
home about us pipeline investors research news events careers sitemap contact© 2008 BionorImmuno, Inc. All rights Reserved
ABOUT US PIPELINE RESEARCH NEWS SITEMAP CONTACT US EVENTS CAREERS HOME INVESTORSBionor Immuno AS, a subsidary of Bionor Pharma ASA was established on July 14th 2000 as a spin off from the R&D on immune based therapies that until then had been performed by its sister company, Bionor AS. Both companies are located at the Telemark Biomedical Centre, Skien, Norway together with two of its development partners AS Telelab and Mericon AS.